Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ETCompany ParticipantsBill Szablewski - Head of Capital MarketsScott Smith ...

Malaysia's semiconductor industry, currently accounting for approximately 7% of global semiconductor exports with annual revenue of around RM575 billion (approx. US$130 billion), stands at a ...

Viatris Inc. reported its first-quarter earnings for 2025, revealing a slight miss on both earnings per share (EPS) and revenue compared to analysts’ forecasts. The company posted an EPS of $0. ...

Because the 'equator' of an egg can withstand more shock, packaging should be better designed to protect the two more breakable ends. What's more, if we were to pick them up horizontally out of ...

Major names of GLP-1 receptor agonists, some of which are used to treat diabetes, include semaglutide (Wegovy and Ozempic), tirzepatide (Mounjaro), liraglutide (Saxenda) and exenatide (a drug which ...

Viatris Inc. reported its first-quarter earnings for 2025, revealing a slight miss on both earnings per share (EPS) and revenue compared to analysts’ forecasts. The company posted an EPS of $0.50, ...

The latest attempt focuses on liraglutide, an older, once-daily injectable product in Novo Nordisk's GLP-1 agonist franchise sold as Victoza and Xultophy for diabetes and Saxenda for obesity.

Amidst the growing concerns over plastic waste and the evolving landscape of environmental regulations, the pharmaceutical industry, known for its heavy reliance on plastic for various packaging ...

Semaglutide is available for private prescription for weight loss under the Wegovy brand, alongside two other GLP-1s: Mounjaro (a brand of tirzepatide) and Saxenda (a brand of liraglutide).

To investigate whether Liraglutide had a neuroprotective after cardiac arrest and return of spontaneous circulation (CA/ROSC) and explore its potential mechanisms. Adopting an 8-min asphyxial cardiac ...